Evaluation and control of hypertensive diabetics seen in Primary Care centres in Spain. BRAND II study;Evaluación y control de los hipertensos diabéticos atendidos en centros de Atención Primaria de España. Estudio BRAND II

Atencion Primaria

Volumn 43, Issue 6, 2011, Pages 297-304

  Abellán Alemán, José ^a   Díaz, Miguel Ángel Prieto ^a   Hernández, Mariano Leal ^a   Galindo, Serafín Balanza ^a   Iserte, Alex De La Sierra ^a   Claros, Nieves Martell ^a   Romanos, Fernando García ^a  

^a HTA SEHLELHA ^*  (Spain)

Author keywords

Control; Diabetes; Hypertension; Primary care; Treatment

Indexed keywords

BIGUANIDE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SULFONYLUREA;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY HEIGHT; BODY WEIGHT; CLINICAL EVALUATION; DIABETES MELLITUS; DIABETIC HYPERTENSION; DIABETIC PATIENT; DISEASE CONTROL; GLUCOSE BLOOD LEVEL; HEALTH CENTER; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; PRIMARY MEDICAL CARE; SPAIN; WAIST CIRCUMFERENCE;

ADULT; AGED; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; SPAIN;

EID: 79958055742     PISSN: 02126567     EISSN: 15781275     Source Type: Journal    
DOI: 10.1016/j.aprim.2010.05.016     Document Type: Article

References (28)

1. C. Arauz-Pacheco, M.A. Parrot, and P. Raskin The treatment of hypertension in adult patients with diabetes Diabetes Care. 25 2002 134 147
2. H.H. Parving Controlling hypertension in diabetes Acta Diabetol. 39 Suppl 2 2002 S35 S40
3. A. Rodríguez, J. Banegas, B. de Andrés, and J. del Rey Principios de prevención cardiovascular Med Clin (Barc). 112 1999 459 464
4. S. Julius, S. Majahalme, and P. Palatini Antihypertensive treatment of patients with diabetes and hypertension Am J Hypertens. 14 2001 310S 316S (Pubitemid 33033101)
5. UKPDS Group: High Blood Pressure control and risk of macrovascular and microvascular manifestations in type 2 Diabetes (UKPDS 38). BMJ. 1998;317:201-72.
6. A. Zanchetti, and L.M. Ruilope Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials? J Hypertens. 20 2002 2099 2110 (Pubitemid 35388221)
7. G.L. Bakris, M. Williams, L. Dworkin National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group Preserving renal function in adults with hypertension and diabetes: a consensus approach Am J Kidney Dis. 36 2000 646 661
8. E. Ritz, and R. Dikow Hypertension and antihypertensive treatment of diabetic nephropathy Nat Clin Pract Nephrol. 2 2006 562 567 (Pubitemid 44465678)
9. G. Mancia, S. Laurent, E. Agabiti-Rosei, E. Ambrosioni, M. Burnier, and M.J. Caulfield Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document Blood Press. 18 2009 308 347
10. M.C. Riddle, W.T. Ambrosius, D.J. Brillon, J.B. Buse, R.P. Byington, R.M. Cohen Action to Control Cardiovascular Risk in Diabetes Investigators Epidemiologic relationships between A1C and all-cause mortality during a median 3. 4-year follow-up of glycemic treatment in the ACCORD trial Diabetes Care. 33 2010 983 990
11. D.E. Bonds, M.E. Miller, R.M. Bergenstal, J.B. Buse, R.P. Byington, and J.A. Cutler The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study BMJ. 340 2010 b4909
12. H. Krum, J.J. McMurray, E. Horton, T. Gerlock, B. Holzhauer, and L. Zuurman Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials Cardiovasc Ther. 28 2010 124 132
13. D. Darwin, and A. Einsten Metabolic syndrome: Time for action American Family Physican. 69 2004 2875 2888
14. F. Civeira, E. Meriño, J. Mozota, and J.A. Pinillo Síndrome metabólico Medicine. 9 2004 1131 1139
15. B. Costa, J.J. Cabré, and F. Martín Síndrome metabólico. Resistencia a la Insulina y diabetes. ¿Qué se oculta bajo la punta del iceberg? Atención Primaria. 31 2003 436 445 (Pubitemid 36966101)
16. C. Yosefy, D. Dicker, J.R. Viskoper, T.H. Tulchinsky, G.M. Ginsberg, and E. Leibovitz The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortality Prev Med. 37 2003 571 576 (Pubitemid 37443496)
17. W.H. Bestermann, D.T. Lackland, J.E. Riehle, and B.M. Egan A systematic approach to managing hypertension and the metabolic syndrome in primary care South Med J. 97 2004 932 938 (Pubitemid 39391819)
18. J.R. Sowers Treatment of hypertension in patients with diabetes Arch Intern Med. 164 2004 1850 1857 (Pubitemid 39294736)
19. J.R. Petrie, S.H. Uede, D.J. Webb, H.L. Elliot, and J.M.C. Connell Endothelial nitric oxide production and insulin resistance syndrome Circulation. 93 1996 1331 1333
20. Hypertension management in adults with diabetes American Diabetes Association Diabetes Care. 2004;27:S65-7.
21. N.R. Roberto, J. Velasco, C. Mena, E. Angulo, T. Garrote MICREX Study Microalbuminuria in diabetic and hypertensive patients: a study of 979 patients Med Clin (Barc). 25 2006 761 764 (Pubitemid 46129141)
22. P. De Pablos-Velasco, O. González-Albarrán, V. Estopiñan, and A. Khanbhai Blood pressure, antihypertensive treatment and factors associated with good blood pressure control in hypertensive diabetics: the Tarmidas study J Hum Hypertens. 21 2007 664 672 (Pubitemid 47162729)
23. B. Álvarez, M. Luque, N. Martell, M.D. López-Eady Investigadores del estudio VAS-HTA Rev Clin Esp. 206 2006 477 484
24. ThR. Dawber The Framingham Study. The epidemiology of atherosclerotic disease 1980 Harvard University Press Cambridge
25. O. García, J.V. Lozano, O. Vegazo, F.J. Jiménez, J.L. Llisterri, and J. Redón Control de la presión arterial de los pacientes diabéticos en el ámbito de Atención Primaria. Estudio DIAPA Med Clin (Barc). 120 2003 529 534 (Pubitemid 36608988)
26. A.H. Barnett, S.C. Bain, and P. Bouter Angiotensin-receptor blockade versus converting-enzime inhibitionin type 2 diabetes and nephropathy N Engl J Med. 351 2004 1952 1961 (Pubitemid 39447136)
27. Grupo de estudio sobre el abordaje farmacológico de la hipertensión en Atención Primaria (AFHAP) Selección del tratamiento farmacológico de la hipertensión arterial en Atención Primaria Med Clin (Barc). 14 2001 374 377
28. A. Zanchetti, G. Mancia, H.R. Black, S. Oparil, B. Waeber, and R.E. Schmieder Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension J Hypertens. 27 2009 673 679